Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ALDEN CANCER THERAPY AS
AS
Active
Org 912772438
Thormøhlens Gate 51, 5006
Bergen
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2013
0 employees
Watchlist
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ALDEN CANCER THERAPY AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2020
-1M
2021
-1M
2022
-1M
2023
-1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 200
0
0
0
0
Staff expenses
−0
−0
−171
−409
−371
EBITDA
1 169
−801
−540
−1 409
−1 423
Depreciation & amort.
−347
−447
−447
−447
−447
EBIT
822
−1 248
−987
−1 856
−1 870
Net financials
4
−2
3
3
9
Profit before tax
826
−1 250
−984
−1 854
−1 861
Tax
−0
−0
−0
−0
−0
Net profit
826
−1 250
−984
−1 854
−1 861
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
4 200
3 082
2 757
2 867
1 790
Equity
3 154
1 904
956
−898
−2 759
Long-term debt
1 000
1 000
1 741
3 741
4 526
Short-term debt
46
178
59
24
23
Total debt
1 046
1 178
1 801
3 765
4 549
Financial ratios
5-year trend
EBITDA margin
-142296900.0%
This company
15.8%
Market median
-900613391% vs market
2020
2024
Equity ratio
-154.1%
This company
38.2%
Market median
-503% vs market
2020
2024
Return on equity
-186127800.0%
This company
18.4%
Market median
-1011564230% vs market
2020
2024
Net profit margin
-186127800.0%
This company
8.1%
Market median
-2297874174% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.65×
This company
0.62×
Market median
-166% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on ALDEN CANCER THERAPY AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
